INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Hywin Holdings Ltd. (HYW) on Behalf of Investors
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces an investigation on behalf of Hywin Holdings Ltd. (“Hywin” or the “Company”)... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of The Estee Lauder Companies Inc. (EL) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of The Estee Lauder Companies Inc. (“Estee Lauder” or the... Read more.
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Blue Ridge Bankshares, Inc. (BRBS) Investors
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of Amtech Systems, Inc. (ASYS) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Amtech Systems, Inc. (“Amtech” or the “Company”) (NASDAQ:... Read more.
BrainChip Previews Industry’s First Edge Box Powered by Neuromorphic AI IP
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial producer of ultra-low... Read more.
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI
First and only hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor approved for these adult patients with advanced RCC This approval of WELIREG marks the first... Read more.
The Law Offices of Frank R. Cruz Announces Investigation of Hywin Holdings Ltd. (HYW) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ:... Read more.
Karuna Therapeutics Announces The Lancet Publication of Data from Phase 3 EMERGENT-2 Trial Evaluating KarXT in Schizophrenia
KarXT demonstrated statistically significant and clinically meaningful improvements in positive and negative symptoms of schizophrenia compared to placebo, as measured... Read more.
Corebridge Financial Announces $150 Million Share Repurchase from AIG and Blackstone
HOUSTON–(BUSINESS WIRE)–Corebridge Financial, Inc. (NYSE: CRBG) (“Corebridge”) today announced that it entered into a share repurchase agreement... Read more.
Steel Partners Holdings L.P. Announces Reverse/Forward Unit Split
NEW YORK–(BUSINESS WIRE)–Steel Partners Holdings L.P. (NYSE: SPLP), a Delaware limited partnership (the “Company” or “Steel Partners”), announced... Read more.